PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.68%
Negative revenue growth while ON stands at 1.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
9.32%
Gross profit growth under 50% of ON's 87.85%. Michael Burry would be concerned about a severe competitive disadvantage.
43.39%
EBIT growth below 50% of ON's 138.01%. Michael Burry would suspect deeper competitive or cost structure issues.
33.50%
Operating income growth under 50% of ON's 133.71%. Michael Burry would be concerned about deeper cost or sales issues.
15.24%
Net income growth under 50% of ON's 135.03%. Michael Burry would suspect the firm is falling well behind a key competitor.
20.00%
EPS growth under 50% of ON's 135.65%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
20.00%
Diluted EPS growth under 50% of ON's 135.65%. Michael Burry would worry about an eroding competitive position or excessive dilution.
45.37%
Slight or no buybacks while ON is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
42.90%
Slight or no buyback while ON is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-33.23%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-24.69%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-19.83%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-33.03%
Negative 10Y revenue/share CAGR while ON stands at 71.75%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-57.43%
Negative 5Y CAGR while ON stands at 19.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-63.08%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-37.86%
Negative 5Y OCF/share CAGR while ON is at 17.99%. Joel Greenblatt would question the firm’s operational model or cost structure.
-46.80%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
12.76%
Below 50% of ON's 245.86%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-27.94%
Negative 5Y net income/share CAGR while ON is 12132.26%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-56.65%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
115.41%
Below 50% of ON's 411.86%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.97%
Below 50% of ON's 142.72%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.40%
Below 50% of ON's 54.30%. Michael Burry suspects a serious short-term disadvantage in building book value.
29.25%
Dividend/share CAGR of 29.25% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-1.57%
Negative 5Y dividend/share CAGR while ON stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-33.25%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-2.35%
Firm’s AR is declining while ON shows 12.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
8.42%
Inventory growth well above ON's 0.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.96%
Positive asset growth while ON is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-25.51%
We have a declining book value while ON shows 0.51%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.07%
We’re deleveraging while ON stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.44%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
5.47%
SG&A growth well above ON's 1.18%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.